Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
(NASDAQ: ALGS) Delayed: 5.69 +0.41 (7.77%)
Previous Close $5.28    52 Week High $ 
Open $5.30    52 Week Low $ 
Day High $5.69    P/E N/A 
Day Low $5.26    EPS $ 
Volume 103,223       

(NASDAQ: ALGS) Delayed: 5.69 +0.41 (7.77%)
Previous Close $5.28    52 Week High $ 
Open $5.30    52 Week Low $ 
Day High $5.69    P/E N/A 
Day Low $5.26    EPS $ 
Volume 103,223